View in EDS HTML Full Text PDF Full Text

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation.

Saved in:
Bibliographic Details
Title: GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation.
Authors: Movahednasab, Maedeh1,2 (AUTHOR) maedehmovahednasab@yahoo.com, Dianat-Moghadam, Hassan1,2 (AUTHOR) Dianat.h@med.mui.ac.ir, Khodadad, Sana3 (AUTHOR) sanakh995@gmail.com, Nedaeinia, Reza2 (AUTHOR) reza.nedaie@gmail.com, Safabakhsh, Saeid4 (AUTHOR) drssafa@gmail.com, Ferns, Gordon5 (AUTHOR) G.Ferns@bsms.ac.uk, Salehi, Rasoul1,2 (AUTHOR) r_salehi@med.mui.ac.ir
Source: Diabetology & Metabolic Syndrome. 2/17/2025, Vol. 17 Issue 1, p1-27. 27p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17585996
DOI:10.1186/s13098-025-01623-w